Stratos Wealth Partners’s West Pharmaceutical WST Stock Holding History

Stratos Wealth Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-916	Closed	-$362K	–	1455
2024 Q1	$362K	Buy	+916	New	+$339K	0.01%	1019
2022 Q3	–	Sell	-868	Closed	-$263K	–	1234
2022 Q2	$263K	Sell	868 -684	-44%	-$223K	0.01%	988
2022 Q1	$638K	Sell	1,552 -227	-13%	-$88.9K	0.01%	715
2021 Q4	$835K	Sell	1,779 -651	-27%	-$280K	0.02%	615
2021 Q3	$1.03M	Buy	2,430 +1,389	+133%	+$586K	0.03%	516
2021 Q2	$374K	Buy	+1,041	New	+$344K	0.01%	880
2018 Q4	–	Sell	-54	Closed	-$7K	–	2518
2018 Q3	$7K	Buy	+54	New	+$6.06K	﹤0.01%	2337
2018 Q2	–	Sell	-54	Closed	-$5K	–	2604
2018 Q1	$5K	Hold	54	–	–	﹤0.01%	2625
2017 Q4	$5K	Buy	+54	New	+$5.29K	﹤0.01%	2409

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stratos Wealth Partners's WST Position: Q2 2024 in Review

Stratos Wealth Partners sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 916 shares — an estimated $362K sold.

Stratos Wealth Partners first reported a position in WST in Q4 2017 and held it in 9 quarters. The position peaked at $1.03M in Q3 2021. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

Stratos Wealth Partners reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Stratos Wealth Partners sold 916 West Pharmaceutical shares in Q2 2024, an estimated $362K.
Stratos Wealth Partners first reported a position in West Pharmaceutical in Q4 2017 and held it in 9 quarters.
Stratos Wealth Partners's West Pharmaceutical position peaked at $1.03M in Q3 2021.
776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Stratos Wealth Partners's 13F filing for Q2 2024, filed 24 Jul 2024.